Low-dose lithium supplementation promotes musculoskeletal and metabolic health in ovariectomized female mice.
Abstract
Postmenopausal women have an increased risk for age-related conditions like sarcopenia, osteoporosis and type 2 diabetes. Here we examined the effects of low-dose lithium (Li) supplementation, a well-known glycogen synthase kinase 3 (GSK3) inhibitor, on ovariectomized (OVX) mice, focusing on muscle strength and endurance, bone mineral density (BMD) and insulin sensitivity. 28-week-old female sham and OVX C57BL/6J mice were divided into three groups: sham, OVX and OVX-Li, with the latter receiving 50 mg/kg/day of Li in their drinking water for 8 weeks. Li supplementation enhanced isometric specific force and fatigue resistance of the soleus and extensor digitorum longus (EDL) muscles. Potential cellular mechanisms underlying these benefits include enhanced Ca
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Low-dose lithium supplementation enhances muscle strength and endurance, bone mineral density, and insulin sensitivity in ovariectomized female mice. The study addresses potential interventions for age-related conditions, which aligns with longevity research by exploring mechanisms that could mitigate the effects of aging.
Author of this paper? Send a correction.